Thermo Fisher wins contracts as pharma shifts production to US, CEO says

Core Insights - Thermo Fisher Scientific's pharmaceutical services business has secured multiple contracts aimed at assisting clients in relocating production from Europe or Asia to the U.S. [1] Company Summary - The CEO of Thermo Fisher Scientific, Marc, highlighted the company's strategic focus on expanding its pharmaceutical services to support clients in shifting their manufacturing operations to the U.S. [1]